Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVAX - eFFECTOR Therapeutics CEO Dr. Steve Worland - Outsmarting Cancer (Video)


NVAX - eFFECTOR Therapeutics CEO Dr. Steve Worland - Outsmarting Cancer (Video)

  • eFFECTOR Therapeutics is a biopharmaceutical company focused on development of selective translation regulation inhibitors (STRIs) for treating cancer.
  • CEO Dr. Steve Worland discusses its 2 drugs in clinical trials and collaboration with Pfizer.
  • Going public in Q3 2021 through SPAC Locust Walk Acquisition.

For further details see:

eFFECTOR Therapeutics CEO Dr. Steve Worland - Outsmarting Cancer (Video)
Stock Information

Company Name: Novavax Inc.
Stock Symbol: NVAX
Market: NASDAQ
Website: novavax.com

Menu

NVAX NVAX Quote NVAX Short NVAX News NVAX Articles NVAX Message Board
Get NVAX Alerts

News, Short Squeeze, Breakout and More Instantly...